infliximab therapy for inflammatory bowel disease – seven years on
complementary and alternative medicine in the irritable bowel syndrome
Healing of lymphocytic gastritis after Helicobacter pylori eradication therapy – a randomized, double-blind, placebo-controlled multicentre trial
Efficacy and safety of rifabutin-containing ‘rescue therapy’ for resistant Helicobacter pylori infection
Upper gastrointestinal mucosal abnormalities and blood loss complicating low-dose aspirin and antithrombotic therapy
Variants of OCTN1–2 cation transporter genes are associated with both Crohn's disease and ulcerative colitis
Long-term follow-up of chronic hepatitis C patients with sustained virological response to various forms of interferon-based anti-viral therapy
A comparison of sirolimus vs. calcineurin inhibitor-based immunosuppressive therapies in liver transplantation
Validation of a 7-point Global Overall Symptom scale to measure the severity of dyspepsia symptoms in clinical trials
Validation of a symptom diary for patients with gastro-oesophageal reflux disease
A prospective randomized blinded comparison of sodium phosphate and polyethylene glycol-electrolyte solution for safe bowel cleansing
Associations between the IGF system and inflammatory markers in inflammatory bowel disease
Associations between the IGF system and inflammatory markers in inflammatory bowel disease
Is oral ciclosporin necessary to switch from i.v. to thiopurines?
Is oral ciclosporin necessary to switch from i.v. to thiopurines?